The research is focused on identifying biomarkers, non-ambulatory endpoints in duchenne muscular dystrophy. Funds will allow recruitment of 100 additional subjects and expand the study through the 20
Treatment methods with IL-17E include single and combination therapy along with anticancer drugs such as gemcitabine, paclitaxel, docetaxel, erlotinib, cisplatin and bevacizumab. Patent also protects the treatment of
Levonorgestrel and Ethinyl Estradiol Tablets are the generic equivalent to Watson Laboratories’ Lutera 28 tablets indicated to prevent pregnancy in women. Lupin is expected to begin the product
Adaptimmune will make use of PCT services in the development of its NYESO-1c259-T cell therapy targeting various oncology indications. Adaptimmune chief executive officer James Noble said, "With our
US patent protects various aspects of the cell-based product including rhodamine derivative’s composition of matter, vital steps involved in ATIR manufacturing process and therapeutic use of ATIR in
The collaboration aims at leveraging Amunix’s XTEN half-life extension technology in Janssen’s protein and/or peptide therapeutics. Amunix president Volker Schellenberger said XTEN polymer can be integrated with a
The alliance will also focus on commercializing network, thereby enhancing the rate of translating academic research into new medicines. Founding organizations include The Centre for Drug Research and
The study is designed to assess rIX-FP’s safety, efficacy and pharmacokinetic profile in children who previously received treatment. CSL Behring along with its parent company, CSL Limited, is
University of Toronto professor and vice-chair of medicine and University Health Network IPF researcher and consultant respirologist Charles Chan said, "Esbriet really is a game-changer. I am excited
Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and Denmark during the first six months of 2013 and in other states all through
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.